Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
8+Product Categories
500+Product Variants
MultipleDosage Forms
GMPQuality Sourced
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
Page 11 of 22
Tablet
Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg is a tablet formulated with Glimepiride 4mg + Metformin Hydrochloride (SR) 500mg. The listed active ingredient profile is Glimepiride; Metformin Hydrochloride, placing the product in the oral antidiabet
Bilayered Tablet
Glimepiride Img + Metformin HCI (SR) 500mg Tab. (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride Img + Metformin HCI (SR) 500mg . ( ). The listed active ingredient profile is Glimepiride Img; Metformin HCI, placing the product in the
Bilayered Tablet
Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg Tablets IP (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride Img + Metformin Hcl (Prolonged Released) 1000mg IP ( ). The listed active ingredient profile is Glimepiride Img;
Tablet
Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg Tablets IP (Uncoated Blayered) is a tablet formulated with Glimepiride Img + Metformin Hcl (Prolonged Released) 500mg IP ( Blayered). The listed active ingredient profile is Glimepiride Img; Metfo
Tablet
Glimepiride Img Tab. (Uncoated) is a tablet formulated with Glimepiride Img . ( ). The listed active ingredient profile is Glimepiride Img, placing the product in the oral antidiabetic category. The formulation contains one or more oral glucose-lowering m
Bilayered Tablet
Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride IP 0.5 mg + Metformin Hydrochloride 500 mg ( ). The listed active ingredient profile is Glimepiride; Metformin Hydrochlori
Bilayered Tablet
Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg Tablets (Uncoated Bilayered) is a bilayered tablet formulated with Glimepiride lmg, Metformin Hcl (Sustained Released) 50mg + Voglibose 0.2mg ( ). The listed active ingredient prof
Bilayered Tablet
Glimepiride lP 4 mg + Metformin IP 1000 mg (Uncoated bilayered Tablet) is a bilayered tablet formulated with Glimepiride lP 4 mg + Metformin IP 1000 mg ( ). The listed active ingredient profile is Glimepiride lP; Metformin, placing the product in the oral
Tablet
Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg is a tablet formulated with Glimepirlde 3mg + Metformin Hydrochloride (SR ) 500mg. The listed active ingredient profile is Glimepirlde; Metformin Hydrochloride, placing the product in the oral antidiab
Tablet
Glipizide 5 mg + Metformin 500 mg Tablets (Uncoated Tab) is a tablet formulated with Glipizide 5 mg + Metformin 500 mg ( ). The listed active ingredient profile is Glipizide; Metformin, placing the product in the oral antidiabetic category. The formulatio
Tablet
Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg Tablet (ilm coated) is a tablet formulated with Gllbenclamide 5mg, Mettorrmin Hydrochloride 500mg + Piogltazone Hydrochloride 15mg (ilm coated). The listed active ingredien
Topical Formulation
Halobetasol Propionate 0.05./w/w + Salicylic Acid 67%w/w is a topical formulation formulated with Halobetasol Propionate 0.05./w/w + Salicylic Acid 67%w/w. The listed active ingredient profile is Halobetasol Propionate ./w/w; Salicylic Acid w/w, placing t
Topical Formulation
Halobetasol Propionate 0.5mg + Salicylic Acid 30mg is a topical formulation formulated with Halobetasol Propionate 0.5mg + Salicylic Acid 30mg. The listed active ingredient profile is Halobetasol Propionate; Salicylic Acid, placing the product in the topi
Topical Formulation
Halobetasol Propionate USP 0.05%w/w + Clotrimazole IP 1%w/w is a topical formulation formulated with Halobetasol Propionate USP 0.05%w/w + Clotrimazole IP 1%w/w. The listed active ingredient profile is Halobetasol Propionate w/w; Clotrimazole w/w, placing
Ointment
Halobetasol Propionate USP 0.05%w/w + Salicylic Acid IP 6% Ointment is a ointment formulated with Halobetasol Propionate USP 0.05%w/w + Salicylic Acid IP 6%. The listed active ingredient profile is Halobetasol Propionate w/w; Salicylic Acid %, placing the
Ointment
Halobetasol Propionate USP 0.5 mg Salicylic Acid IP 30 mg Ointment is a ointment formulated with Halobetasol Propionate USP 0.5 mg Salicylic Acid IP 30 mg. The listed active ingredient profile is Halobetasol Propionate Salicylic Acid, placing the product
Topical Formulation
Halobetasole Propionate 0.05w/w + Clotrimazole 1%w/w is a topical formulation formulated with Halobetasole Propionate 0.05w/w + Clotrimazole 1%w/w. The listed active ingredient profile is Halobetasole Propionate; Clotrimazole w/w, placing the product in t
Dosage form on request
Steroidal progestogens, androgens, and reproductive biologics for endocrine regulation and fertility therapy. Supplied in pharmaceutical grade for injectable, oral, and topical formulation manufacturing.
Topical Formulation
Hydroquinone 2%w/w + Tretinoin 0.025%w/w + Mometasone Furoate 0.10%w/w is a topical formulation formulated with Hydroquinone 2%w/w + Tretinoin 0.025%w/w + Mometasone Furoate 0.10%w/w. The listed active ingredient profile is Hydroquinone w/w; Tretinoin w/w
Topical Formulation
Hydroquinone 2%w/w Tertinoin 0.025%w/w + Fluocinolone Acetonide 0.01%w/w is a topical formulation formulated with Hydroquinone 2%w/w Tertinoin 0.025%w/w + Fluocinolone Acetonide 0.01%w/w. The listed active ingredient profile is Hydroquinone w/w Tertinoin
Film-Coated Tablet
Hyoscine Butylbromide 10 mg + Paracetamol 325 mg Film-Coated Tablet is a film-coated tablet formulated with Hyoscine Butylbromide 10 mg + Paracetamol 325 mg. The active ingredient profile is Hyoscine Butylbromide; Paracetamol, placing the product in the a
GMP Certified Manufacturers
Wide Product Portfolio
Multiple Dosage Forms
Global Supply Network
Regulatory Documentation
Competitive PricingOur sourcing experts are ready to help with custom requirements, supply availability and regulatory documentation.
